Life Sciences

Comprehensive Approach
Data Driven Insight
We work with pharmaceutical and medical technology firms to align business, operations, research and information technology in order to transform their organization and improve portfolio performance.
Steve Sapletal
After A Blockbuster 2014, What Will 2015 Hold For Pharmaceutical M&A?
2014 was a banner year for mergers and acquisitions globally, but few sectors dominated the deal-making cycle like pharmaceuticals and biotech.

As you face regulatory shifts, profit pressures and an accelerated M&A environment, is your organization focused on thriving and growing over the next five years?

If so, then three items are likely at the top of your operations agenda: leverage analytics, drive greater efficiencies and master M&A transformations. We can assist with all three: We extract deep insights from complex data arrays using advanced approaches and tools like the Bearing Point HyperCube. We help you use these insights to structure and run your operations more intelligently, efficiently and profitably—and with greater foresight. We navigate the complexities of any M&A process by planning and executing diligence, acquisition and carve out projects complete with tools, templates and processes that give you tighter control and more predictable outcomes.

Sound like magic sauce? Perhaps, but clients tell us that our approach is comprehensive and the results are real.

Data Management
Many of today’s pharmaceutical companies have been formed by a variety of mergers, acquisitions, divestitures and joint ventures, making data management and systems integration an overwhelming burden. We can help.
Predictive Analytics
International regulators are requiring Life Science companies to identify biomarkers and related characteristics that correlate to patient outcomes. While analytics in the industry are advanced, there is strong demand for new technologies to quickly identify predictive variables from complex data sets.
Join West Monroe, Align Networks and Hospira as we discuss lessons learned from previous transactions
Date : November 24, 2014 Time : 12:00 PM CST
How do you build an M&A playbook? What works well? Where does it fall down? We'll discuss key lessons learned and our panelists from Align Networks and Hospira share their perspectives on the benefits and pitfalls of playbooks.
Munzoor Shaikh speaks at iiBIG's fall M&A conference
Date : October 16, 2014
Join West Monroe at the International Institute for Business Information & Growth's "Investment and M&A Opportunities in Healthcare" conference in October. Munzoor Shaikh and a panel of experts will discuss the role of technology in healthcare M&A transactions.
Join West Monroe as we discuss how to manage the complexity of deal activity in the life sciences industry
Date : October 3, 2013 Time : 11:00 AM CST
McDermott Will & Emery’s second annual Life Sciences Private Equity Dealmaking Symposium will focus on the opportunities and challenges for those investing and operating in the multibillion dollar life sciences industry. The event will feature a seasoned panels of private equity, investment bank, pharmaceutical, biotechnology, and medical products and services leaders who will provide insight and guidance into how to address the ever-changing landscape.